HUGE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	1.20M
平均成交量	210 196
市值	14.96M
EPS	$0 ( 2024-04-01 )
下一个收益日期	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.800
ATR14	$0.00200 (0.54%)

音量相关性

長: 0.08 (neutral)

短: 0.00 (neutral)

Signal:(47.401) Neutral

FSD Pharma Inc 相关性

10 最正相关
APVO	0.948
VGFC	0.944
SHEN	0.943
WKSP	0.943
MBIN	0.941
GMVD	0.938
JRJC	0.934
MIGI	0.933
TREE	0.932
GLPG	0.932

10 最负相关
IVCB	-0.945
AEYE	-0.941
ALSA	-0.939
MSSA	-0.939
TZPS	-0.939
TZPSU	-0.933
MPRA	-0.932
MLAI	-0.93
VITL	-0.929
VCTR	-0.927

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

FSD Pharma Inc 相关性 - 货币/商品

-0.24
( neutral )

-0.23
( neutral )

0.00
( neutral )

-0.45
( neutral )

0.26
( neutral )

FSD Pharma Inc 财务报表

Annual	2023
营收:	$0
毛利润:	$-2.55M (0.00 %)
EPS:	$-0.470

FY	2023
营收:	$0
毛利润:	$-2.55M (0.00 %)
EPS:	$-0.470

FY	2022
营收:	$0
毛利润:	$-4.36M (0.00 %)
EPS:	$-0.600

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.010

Financial Reports:

No articles found.

FSD Pharma Inc

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.